aluates Reports

$ 0.0

Automative

Global Cannabis Use Disorder Treatment Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-8R13490

Global Cannabis Use Disorder Treatment Market Research Report 2023

BUY CHAPTERS

Global Cannabis Use Disorder Treatment Market Research Report 2025

Code: QYRE-Auto-8R13490

Report

May 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Alkermes plc

BioCorRx Inc

Cipla Ltd

Dr. Reddy’s Laboratories

Glenmark Pharmaceuticals Limited

Intas Pharmaceuticals Limited

Mallinckrodt plc

Noramco

Orexo

Purdue Pharma

Cannabis Use Disorder Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cannabis Use Disorder Treatment Market

The global market for Cannabis Use Disorder Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cannabis Use Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Use Disorder Treatment.

The Cannabis Use Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cannabis Use Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cannabis Use Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cannabis Use Disorder Treatment Market Report

Report Metric	Details
Report Name	Cannabis Use Disorder Treatment Market
CAGR	5%
Segment by Type	Tobacco/Nicotine and Vaping Alcohol Marijuana Synthetic Cannabinoids Others
Segment by Application	Hospitals and Clinics Rehabilitation Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, Orexo AB, Purdue Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabis Use Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cannabis Use Disorder Treatment Market report?

Ans: The main players in the Cannabis Use Disorder Treatment Market are AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, Orexo AB, Purdue Pharma

What are the Application segmentation covered in the Cannabis Use Disorder Treatment Market report?

Ans: The Applications covered in the Cannabis Use Disorder Treatment Market report are Hospitals and Clinics, Rehabilitation Centers, Others

What are the Type segmentation covered in the Cannabis Use Disorder Treatment Market report?

Ans: The Types covered in the Cannabis Use Disorder Treatment Market report are Tobacco/Nicotine and Vaping, Alcohol, Marijuana, Synthetic Cannabinoids, Others

Recommended Reports

Addiction Treatment

Mental Health Disorders

Substance & Drug Screening

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tobacco/Nicotine and Vaping

1.2.3 Alcohol

1.2.4 Marijuana

1.2.5 Synthetic Cannabinoids

1.2.6 Others

1.3 Market by Application

1.3.1 Global Cannabis Use Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Clinics

1.3.3 Rehabilitation Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cannabis Use Disorder Treatment Market Perspective (2020-2031)

2.2 Global Cannabis Use Disorder Treatment Growth Trends by Region

2.2.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cannabis Use Disorder Treatment Historic Market Size by Region (2020-2025)

2.2.3 Cannabis Use Disorder Treatment Forecasted Market Size by Region (2026-2031)

2.3 Cannabis Use Disorder Treatment Market Dynamics

2.3.1 Cannabis Use Disorder Treatment Industry Trends

2.3.2 Cannabis Use Disorder Treatment Market Drivers

2.3.3 Cannabis Use Disorder Treatment Market Challenges

2.3.4 Cannabis Use Disorder Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cannabis Use Disorder Treatment Players by Revenue

3.1.1 Global Top Cannabis Use Disorder Treatment Players by Revenue (2020-2025)

3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cannabis Use Disorder Treatment Revenue

3.4 Global Cannabis Use Disorder Treatment Market Concentration Ratio

3.4.1 Global Cannabis Use Disorder Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cannabis Use Disorder Treatment Revenue in 2024

3.5 Global Key Players of Cannabis Use Disorder Treatment Head office and Area Served

3.6 Global Key Players of Cannabis Use Disorder Treatment, Product and Application

3.7 Global Key Players of Cannabis Use Disorder Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cannabis Use Disorder Treatment Breakdown Data by Type

4.1 Global Cannabis Use Disorder Treatment Historic Market Size by Type (2020-2025)

4.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2026-2031)

5 Cannabis Use Disorder Treatment Breakdown Data by Application

5.1 Global Cannabis Use Disorder Treatment Historic Market Size by Application (2020-2025)

5.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cannabis Use Disorder Treatment Market Size (2020-2031)

6.2 North America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cannabis Use Disorder Treatment Market Size by Country (2020-2025)

6.4 North America Cannabis Use Disorder Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cannabis Use Disorder Treatment Market Size (2020-2031)

7.2 Europe Cannabis Use Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cannabis Use Disorder Treatment Market Size by Country (2020-2025)

7.4 Europe Cannabis Use Disorder Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cannabis Use Disorder Treatment Market Size (2020-2031)

8.2 Asia-Pacific Cannabis Use Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cannabis Use Disorder Treatment Market Size (2020-2031)

9.2 Latin America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cannabis Use Disorder Treatment Market Size by Country (2020-2025)

9.4 Latin America Cannabis Use Disorder Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cannabis Use Disorder Treatment Market Size (2020-2031)

10.2 Middle East & Africa Cannabis Use Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Cannabis Use Disorder Treatment Introduction

11.1.4 AbbVie Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Alkermes

11.2.1 Alkermes Company Details

11.2.2 Alkermes Business Overview

11.2.3 Alkermes Cannabis Use Disorder Treatment Introduction

11.2.4 Alkermes Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.2.5 Alkermes Recent Development

11.3 BioCorRx

11.3.1 BioCorRx Company Details

11.3.2 BioCorRx Business Overview

11.3.3 BioCorRx Cannabis Use Disorder Treatment Introduction

11.3.4 BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.3.5 BioCorRx Recent Development

11.4 Cipla Limited

11.4.1 Cipla Limited Company Details

11.4.2 Cipla Limited Business Overview

11.4.3 Cipla Limited Cannabis Use Disorder Treatment Introduction

11.4.4 Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.4.5 Cipla Limited Recent Development

11.5 Dr. Reddy’s Laboratories

11.5.1 Dr. Reddy’s Laboratories Company Details

11.5.2 Dr. Reddy’s Laboratories Business Overview

11.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Introduction

11.5.4 Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.5.5 Dr. Reddy’s Laboratories Recent Development

11.6 Glenmark Pharmaceuticals Limited

11.6.1 Glenmark Pharmaceuticals Limited Company Details

11.6.2 Glenmark Pharmaceuticals Limited Business Overview

11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction

11.6.4 Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.6.5 Glenmark Pharmaceuticals Limited Recent Development

11.7 Intas Pharmaceuticals Limited

11.7.1 Intas Pharmaceuticals Limited Company Details

11.7.2 Intas Pharmaceuticals Limited Business Overview

11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction

11.7.4 Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.7.5 Intas Pharmaceuticals Limited Recent Development

11.8 Indivior

11.8.1 Indivior Company Details

11.8.2 Indivior Business Overview

11.8.3 Indivior Cannabis Use Disorder Treatment Introduction

11.8.4 Indivior Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.8.5 Indivior Recent Development

11.9 Mallinckrodt

11.9.1 Mallinckrodt Company Details

11.9.2 Mallinckrodt Business Overview

11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Introduction

11.9.4 Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.9.5 Mallinckrodt Recent Development

11.10 Noramco

11.10.1 Noramco Company Details

11.10.2 Noramco Business Overview

11.10.3 Noramco Cannabis Use Disorder Treatment Introduction

11.10.4 Noramco Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.10.5 Noramco Recent Development

11.11 Orexo AB

11.11.1 Orexo AB Company Details

11.11.2 Orexo AB Business Overview

11.11.3 Orexo AB Cannabis Use Disorder Treatment Introduction

11.11.4 Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.11.5 Orexo AB Recent Development

11.12 Purdue Pharma

11.12.1 Purdue Pharma Company Details

11.12.2 Purdue Pharma Business Overview

11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Introduction

11.12.4 Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2020-2025)

11.12.5 Purdue Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Alkermes plc

BioCorRx Inc

Cipla Ltd

Dr. Reddy’s Laboratories

Glenmark Pharmaceuticals Limited

Intas Pharmaceuticals Limited

Mallinckrodt plc

Noramco

Orexo

Purdue Pharma

List of Tables

Table 1. Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tobacco/Nicotine and Vaping

Table 3. Key Players of Alcohol

Table 4. Key Players of Marijuana

Table 5. Key Players of Synthetic Cannabinoids

Table 6. Key Players of Others

Table 7. Global Cannabis Use Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Cannabis Use Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Cannabis Use Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Cannabis Use Disorder Treatment Market Share by Region (2020-2025)

Table 11. Global Cannabis Use Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Cannabis Use Disorder Treatment Market Share by Region (2026-2031)

Table 13. Cannabis Use Disorder Treatment Market Trends

Table 14. Cannabis Use Disorder Treatment Market Drivers

Table 15. Cannabis Use Disorder Treatment Market Challenges

Table 16. Cannabis Use Disorder Treatment Market Restraints

Table 17. Global Cannabis Use Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Cannabis Use Disorder Treatment Market Share by Players (2020-2025)

Table 19. Global Top Cannabis Use Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2024)

Table 20. Ranking of Global Top Cannabis Use Disorder Treatment Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Cannabis Use Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Cannabis Use Disorder Treatment, Headquarters and Area Served

Table 23. Global Key Players of Cannabis Use Disorder Treatment, Product and Application

Table 24. Global Key Players of Cannabis Use Disorder Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cannabis Use Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Cannabis Use Disorder Treatment Revenue Market Share by Type (2020-2025)

Table 28. Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Cannabis Use Disorder Treatment Revenue Market Share by Type (2026-2031)

Table 30. Global Cannabis Use Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Cannabis Use Disorder Treatment Revenue Market Share by Application (2020-2025)

Table 32. Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Cannabis Use Disorder Treatment Revenue Market Share by Application (2026-2031)

Table 34. North America Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Cannabis Use Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Cannabis Use Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Cannabis Use Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Cannabis Use Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Cannabis Use Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Cannabis Use Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Cannabis Use Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. AbbVie Company Details

Table 50. AbbVie Business Overview

Table 51. AbbVie Cannabis Use Disorder Treatment Product

Table 52. AbbVie Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 53. AbbVie Recent Development

Table 54. Alkermes Company Details

Table 55. Alkermes Business Overview

Table 56. Alkermes Cannabis Use Disorder Treatment Product

Table 57. Alkermes Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 58. Alkermes Recent Development

Table 59. BioCorRx Company Details

Table 60. BioCorRx Business Overview

Table 61. BioCorRx Cannabis Use Disorder Treatment Product

Table 62. BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 63. BioCorRx Recent Development

Table 64. Cipla Limited Company Details

Table 65. Cipla Limited Business Overview

Table 66. Cipla Limited Cannabis Use Disorder Treatment Product

Table 67. Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 68. Cipla Limited Recent Development

Table 69. Dr. Reddy’s Laboratories Company Details

Table 70. Dr. Reddy’s Laboratories Business Overview

Table 71. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product

Table 72. Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 73. Dr. Reddy’s Laboratories Recent Development

Table 74. Glenmark Pharmaceuticals Limited Company Details

Table 75. Glenmark Pharmaceuticals Limited Business Overview

Table 76. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product

Table 77. Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 78. Glenmark Pharmaceuticals Limited Recent Development

Table 79. Intas Pharmaceuticals Limited Company Details

Table 80. Intas Pharmaceuticals Limited Business Overview

Table 81. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product

Table 82. Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 83. Intas Pharmaceuticals Limited Recent Development

Table 84. Indivior Company Details

Table 85. Indivior Business Overview

Table 86. Indivior Cannabis Use Disorder Treatment Product

Table 87. Indivior Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 88. Indivior Recent Development

Table 89. Mallinckrodt Company Details

Table 90. Mallinckrodt Business Overview

Table 91. Mallinckrodt Cannabis Use Disorder Treatment Product

Table 92. Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 93. Mallinckrodt Recent Development

Table 94. Noramco Company Details

Table 95. Noramco Business Overview

Table 96. Noramco Cannabis Use Disorder Treatment Product

Table 97. Noramco Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 98. Noramco Recent Development

Table 99. Orexo AB Company Details

Table 100. Orexo AB Business Overview

Table 101. Orexo AB Cannabis Use Disorder Treatment Product

Table 102. Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 103. Orexo AB Recent Development

Table 104. Purdue Pharma Company Details

Table 105. Purdue Pharma Business Overview

Table 106. Purdue Pharma Cannabis Use Disorder Treatment Product

Table 107. Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2020-2025) & (US$ Million)

Table 108. Purdue Pharma Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Cannabis Use Disorder Treatment Picture

Figure 2. Global Cannabis Use Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cannabis Use Disorder Treatment Market Share by Type: 2024 VS 2031

Figure 4. Tobacco/Nicotine and Vaping Features

Figure 5. Alcohol Features

Figure 6. Marijuana Features

Figure 7. Synthetic Cannabinoids Features

Figure 8. Others Features

Figure 9. Global Cannabis Use Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Cannabis Use Disorder Treatment Market Share by Application: 2024 VS 2031

Figure 11. Hospitals and Clinics Case Studies

Figure 12. Rehabilitation Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Cannabis Use Disorder Treatment Report Years Considered

Figure 15. Global Cannabis Use Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Cannabis Use Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Cannabis Use Disorder Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Cannabis Use Disorder Treatment Market Share by Players in 2024

Figure 19. Global Top Cannabis Use Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Cannabis Use Disorder Treatment Revenue in 2024

Figure 21. North America Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Cannabis Use Disorder Treatment Market Share by Country (2020-2031)

Figure 23. United States Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Cannabis Use Disorder Treatment Market Share by Country (2020-2031)

Figure 27. Germany Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Cannabis Use Disorder Treatment Market Share by Region (2020-2031)

Figure 35. China Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Cannabis Use Disorder Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Cannabis Use Disorder Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Cannabis Use Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. AbbVie Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 51. Alkermes Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 52. BioCorRx Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 53. Cipla Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 54. Dr. Reddy’s Laboratories Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 55. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 56. Intas Pharmaceuticals Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 57. Indivior Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 58. Mallinckrodt Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 59. Noramco Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 60. Orexo AB Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 61. Purdue Pharma Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Medicinal Cannabis Compounding Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cannabinoid Derived Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Behavioural Health Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cannabinoid based Antitumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disruptive Behavior Disorder DBD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Marijuana MMJ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurologic Disorder Treatment Drug Market Research Report 2024

Global Marijuana Drug Test Kit Market Research Report 2025

Global Alcohol Addiction Therapeutics Market Research Report 2024

Autism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dried Herb Cannabis Vaporizers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Free Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psychedelic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions